DexCom
DXCM
DXCM
723 hedge funds and large institutions have $40.5B invested in DexCom in 2021 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 314 increasing their positions, 200 reducing their positions, and 78 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
11.3% more ownership
Funds ownership: 381.19% → 392.49% (+11%)
9% more first-time investments, than exits
New positions opened: 85 | Existing positions closed: 78
0% less funds holding
Funds holding: 726 → 723 (-3)
Holders
723
Holding in Top 10
8
Calls
$926M
Puts
$589M
Top Buyers
| 1 | +$442M | |
| 2 | +$427M | |
| 3 | +$385M | |
| 4 |
JP Morgan Chase
New York
|
+$376M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$231M |
Top Sellers
| 1 | -$448M | |
| 2 | -$348M | |
| 3 | -$216M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$170M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$129M |